Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

PRESS DIGEST- Financial Times - April 10

Published 10/04/2019, 09:30 am
Updated 10/04/2019, 09:40 am
© Reuters.  PRESS DIGEST- Financial Times - April 10

April 10 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

Indivior charged over alleged scheme to boost prescriptions

https://on.ft.com/2KxqDg6

Debenhams in administration as Ashley cries foul

https://on.ft.com/2KlSHmC

Wynn withdraws $7.1 bln takeover bid for Crown Resorts

https://on.ft.com/2KwpqWK

Overview

The U.S. Department of Justice on Tuesday charged British drugmaker Indivior Plc INDV.L with engaging in a fraudulent marketing scheme to boost prescriptions of an opioid drug known as Suboxone Film that is used to treat opioid addiction.

Struggling department store chain Debenhams Plc DEB.L has gone into administration and its lenders have taken control, after it rejected an eleventh-hour offer of financial support from its biggest shareholder Sports Direct International Plc SPD.L .

Wynn Resorts Ltd WYNN.O , the Las Vegas gaming giant created by billionaire Steve Wynn, abruptly terminated talks to buy Australia's Crown Resorts Ltd CWN.AX , less than 24 hours after Crown disclosed it had received a A$10 billion ($7.13 billion) bid. ($1 = 1.4035 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.